Ian Schapkaitz, MBBCh

Ian Schapkaitz, MBBCh is a contributing author on Psychiatrist.com. Ian Schapkaitz has authored or co-authored 2 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2010 and 2014. Their work focuses on Depression (MDD).

Depression (MDD)

Frequent co-authors

Ashley I. Bush Felicity Ng Gin S. Malhi Kristy Kohlmann Michael Berk Ahmed Munib Barbara Hanna Christine Allwang

Original Research

Efficiency of N-Acetylcysteine in MDD

June 27, 2014

Read about the Efficacy of N-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial.

Michael Berk, Gin S. Malhi, Seetal Dodd, et al

Original Research

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

September 21, 2010

Philippe Conus, Michael Berk, Gin S. Malhi, et al

Ian Schapkaitz, MBBCh

Frequent co-authors

Efficiency of N-Acetylcysteine in MDD

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

ELSEWHERE:

FOLLOW US:

Ian Schapkaitz, MBBCh

Frequent co-authors

Efficiency of N-Acetylcysteine in MDD

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

Live Webinar and Q&A With Dr Deligiannidis

Subscribe to readmore articles

Live Webinar
and Q&A With
Dr Deligiannidis

Subscribe to read
more articles